hexamethonium has been researched along with Depression, Endogenous in 3 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| JACOBOWSKY, B | 1 |
| NORRIS, AS | 1 |
| Scogin, F | 1 |
| Hamblin, D | 1 |
| Beutler, L | 1 |
3 other studies available for hexamethonium and Depression, Endogenous
| Article | Year |
|---|---|
[Psychiatric considerations of hexamethonium].
Topics: Depression; Depressive Disorder; Hexamethonium; Humans; Muscle Relaxants, Central | 1953 |
Diagnosis and treatment of depressin in office practice.
Topics: Depression; Depressive Disorder; Hexamethonium; Humans | 1960 |
Bibliotherapy for depressed older adults: a self-help alternative.
Topics: Aged; Bibliotherapy; Depressive Disorder; Hexamethonium; Hexamethonium Compounds; Humans; Middle Age | 1987 |